Determination of the radiochemical and chemical purity of the radiopharmaceutical drug prostate-specific membrane antigen labeled with lutetium-177 (177Lu-PSMA-617)

Authors

  • Л.О. Хажиев Институт ядерной физики АН РУз
  • И.И. Садиков Институт ядерной физики АН РУз
  • А.М. Абдукаюмов Предпрятиe «Радиопрепарат» ИЯФ АН РУз
  • Ш.А. Мадниязов Предпрятиe «Радиопрепарат» ИЯФ АН РУз

DOI:

https://doi.org/10.52304/.v27i3.600

Keywords:

radiopharmaceuticals, PSMA-617, prostate cancer, radiochemical purity, paper chromatography, atomic emission spectrometry

Abstract

The work is devoted to the development of techniques for determining the radiochemical purity
(the content of the connected target radionuclide) and chemical purity (the content of nonradioactive
impurity elements Cu, Fe, Pb, Zn, Yb, etc. of the radiopharmaceuticals 177Lu-
PSMA-617, produced in the State Enterprise "Radiopreparat". At the development of the techniques,
the methods of paper chromatography and atomic emission spectrometry with inductively
coupled plasma (ICP-AES) are used. The paper chromatography method made it possible
to determine the radiochemical purity of the preparation up to 99.0%, and ICP-AES determined
the limited impurities of Cu, Fe, Pb, Zn, Yb up to 0.35 μg/GBq. The characteristics of
the developed methods fully meet the regulatory requirements established for radiopharmaceuticals.

Published

2025-10-31

How to Cite

Хажиев, Л., Садиков, И., Абдукаюмов, А., & Мадниязов, Ш. (2025). Determination of the radiochemical and chemical purity of the radiopharmaceutical drug prostate-specific membrane antigen labeled with lutetium-177 (177Lu-PSMA-617). “Uzbek Journal of Physics”, 27(3). https://doi.org/10.52304/.v27i3.600

Issue

Section

07. Biophysics and Medical Physics. Chemical physics